Kirk A. Frey - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Neuroscience Biology

170 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jackson IM, Lee SJ, Sowa AR, Rodnick ME, Bruton L, Clark M, Preshlock S, Rothley J, Rogers VE, Botti LE, Henderson BD, Hockley BG, Torres J, Raffel DM, Brooks AF, ... Frey KA, et al. Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC). Ejnmmi Radiopharmacy and Chemistry. 5: 24. PMID 33175263 DOI: 10.1186/s41181-020-00110-z  0.32
2019 Zhou Z, Müller MLTM, Kanel P, Chua J, Kotagal V, Kaufer DI, Albin RL, Frey KA, Bohnen NI. Apathy rating scores and β-amyloidopathy in Parkinson disease patients at risk for cognitive decline. Neurology. PMID 31732566 DOI: 10.1212/Wnl.0000000000008683  0.32
2019 Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM. Cholinergic system changes of falls and freezing of gait in Parkinson disease. Annals of Neurology. PMID 30720884 DOI: 10.1002/Ana.25430  0.32
2018 Albin RL, Bohnen NI, Muller ML, Dauer WT, Sarter M, Frey KA, Koeppe RA. Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [ F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study. The Journal of Comparative Neurology. PMID 30255936 DOI: 10.1002/Cne.24541  0.32
2018 Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Müller MLTM, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [F]-FEOBV. Molecular Psychiatry. PMID 30082840 DOI: 10.1038/S41380-018-0130-5  0.32
2017 Bohnen NI, Haugen J, Ridder A, Kotagal V, Albin RL, Frey KA, Müller MLTM. Color discrimination errors associate with axial motor impairments in Parkinson's disease. Movement Disorders Clinical Practice. 4: 864-869. PMID 29226177 DOI: 10.1002/Mdc3.12527  0.32
2017 Kotagal V, Bohnen NI, Müller ML, Frey KA, Albin RL. Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease. Journal of Parkinson's Disease. PMID 28106566 DOI: 10.3233/Jpd-160985  0.32
2016 Ridder A, Müller ML, Kotagal V, Frey KA, Albin RL, Bohnen NI. Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related Disorders. 34: 15-19. PMID 27742131 DOI: 10.1016/J.Parkreldis.2016.10.006  0.32
2016 Scott PJ, Shao X, Desmond TJ, Hockley BG, Sherman P, Quesada CA, Frey KA, Koeppe RA, Kilbourn MR, Bohnen NI. Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET. Acs Medicinal Chemistry Letters. 7: 746-50. PMID 27563397 DOI: 10.1021/Acsmedchemlett.5B00435  0.32
2016 Albin RL, Frey KA. Reverse Translation in Parkinson Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27151982 DOI: 10.2967/Jnumed.116.175257  0.32
2016 Haugen J, Müller ML, Kotagal V, Albin RL, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26911386 DOI: 10.1007/S00702-016-1524-7  0.32
2016 Petrou M, Davatzikos C, Hsieh M, Foerster BR, Albin RL, Kotagal V, Müller ML, Koeppe RA, Herman WH, Frey KA, Bohnen NI. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. Academic Radiology. PMID 26874576 DOI: 10.1016/J.Acra.2015.07.014  0.32
2015 Shah N, Frey KA, L T M Müller M, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26380951 DOI: 10.1002/Mds.26369  0.32
2015 Snider J, Müller ML, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Albin RL, Bohnen NI. Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration. Parkinsonism & Related Disorders. PMID 26330028 DOI: 10.1016/J.Parkreldis.2015.08.027  0.32
2015 Albin RL, Fisher-Hubbard A, Shanmugasundaram K, Koeppe RA, Burke JF, Camelo-Piragua S, Lieberman AP, Giordani B, Frey KA. Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications. Annals of Neurology. PMID 26183692 DOI: 10.1002/Ana.24481  0.32
2015 Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Langa KM, Albin RL. Educational attainment and motor burden in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1143-7. PMID 26096339 DOI: 10.1002/Mds.26272  0.32
2015 Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA. Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 928-35. PMID 25879534 DOI: 10.1002/Mds.26191  0.32
2015 Curtis C, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN, Beach TG, Duara R, Fleisher AS, Frey KA, Walker Z, Hunjan A, Holmes C, Escovar YM, Vera CX, et al. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. Jama Neurology. 72: 287-94. PMID 25622185 DOI: 10.1001/Jamaneurol.2014.4144  0.32
2015 Thomas AC, Brown RK, Begum R, Srinivasan A, Bohnen NI, Frey KA. Autoimmune limbic encephalitis detected on FDG brain scan performed for the evaluation of dementia. Clinical Nuclear Medicine. 40: 358-9. PMID 25608163 DOI: 10.1097/Rlu.0000000000000702  0.32
2015 Bohnen NI, Albin RL, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. Jama Neurology. 72: 194-200. PMID 25506674 DOI: 10.1001/Jamaneurol.2014.2757  0.32
2015 Müller ML, Bohnen NI, Kotagal V, Scott PJ, Koeppe RA, Frey KA, Albin RL. Clinical markers for identifying cholinergic deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 269-73. PMID 25393613 DOI: 10.1002/Mds.26061  0.32
2014 Bohnen NI, Kotagal V, Müller ML, Koeppe RA, Scott PJ, Albin RL, Frey KA, Petrou M. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related Disorders. 20: 1394-8. PMID 25454317 DOI: 10.1016/J.Parkreldis.2014.10.008  0.32
2014 Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, Scott PJ, Albin RL, Müller ML. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1118-24. PMID 24909584 DOI: 10.1002/Mds.25929  0.32
2014 Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. Acs Chemical Neuroscience. 5: 718-30. PMID 24896980 DOI: 10.1021/Cn500103U  0.32
2014 Kotagal V, Albin RL, Müller ML, Koeppe RA, Studenski S, Frey KA, Bohnen NI. Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 69: 1569-75. PMID 24864306 DOI: 10.1093/Gerona/Glu070  0.32
2014 Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 34: 684-701. PMID 24819789 DOI: 10.1148/Rg.343135065  0.32
2014 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology. 82: 1514-20. PMID 24682965 DOI: 10.1212/Wnl.0000000000000356  0.32
2014 Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 396-404. PMID 24481024 DOI: 10.2967/Jnumed.113.124792  0.32
2013 Arabi M, Brown RK, Dwamena BA, Jakubowski E, Kim K, Alvarez R, Piert M, Frey K. Single-photon emission computed tomography/computed tomography as a problem-solving tool in patients with suspected acute cholecystitis. Journal of Computer Assisted Tomography. 37: 844-8. PMID 24270104 DOI: 10.1097/Rct.0B013E3182A604Ae  0.32
2013 Chung S, Bohnen NI, Albin RL, Frey KA, Müller ML, Chervin RD. Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 9: 1131-7. PMID 24235893 DOI: 10.5664/Jcsm.3150  0.32
2013 Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Müller ML. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 81: 1611-6. PMID 24078735 DOI: 10.1212/Wnl.0B013E3182A9F558  0.32
2013 Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain : a Journal of Neurology. 136: 3282-9. PMID 24056537 DOI: 10.1093/Brain/Awt247  0.32
2013 Albin RL, Burke JF, Koeppe RA, Giordani B, Gilman S, Frey KA. Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 887-93. PMID 23572495 DOI: 10.2967/Jnumed.112.112599  0.32
2013 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1421-4. PMID 23532360 DOI: 10.1007/S00702-013-1013-1  0.32
2013 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism & Related Disorders. 19: 522-6. PMID 23462483 DOI: 10.1016/J.Parkreldis.2013.01.016  0.32
2013 Avram AM, Fig LM, Frey KA, Gross MD, Wong KK. Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging? The Journal of Clinical Endocrinology and Metabolism. 98: 1163-71. PMID 23430789 DOI: 10.1210/Jc.2012-3630  0.32
2013 Müller ML, Frey KA, Petrou M, Kotagal V, Koeppe RA, Albin RL, Bohnen NI. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 296-301. PMID 23239424 DOI: 10.1002/Mds.25213  0.32
2012 Shao X, Carpenter GM, Desmond TJ, Sherman P, Quesada CA, Fawaz M, Brooks AF, Kilbourn MR, Albin RL, Frey KA, Scott PJ. Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles. Acs Medicinal Chemistry Letters. 3: 936-41. PMID 24900410 DOI: 10.1021/Ml300216T  0.32
2012 Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Albin RL. Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Archives of Neurology. 69: 1628-31. PMID 22964894 DOI: 10.1001/Archneurol.2012.764  0.32
2012 Petrou M, Bohnen NI, Müller ML, Koeppe RA, Albin RL, Frey KA. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. 79: 1161-7. PMID 22933741 DOI: 10.1212/Wnl.0B013E3182698D4A  0.32
2012 Lelieveld IM, Müller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, Albin RL. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. Plos One. 7: e40166. PMID 22792235 DOI: 10.1371/Journal.Pone.0040166  0.32
2012 Donohoe KJ, Agrawal G, Frey KA, Gerbaudo VH, Mariani G, Nagel JS, Shulkin BL, Stabin MG, Stokes MK. SNM practice guideline for brain death scintigraphy 2.0. Journal of Nuclear Medicine Technology. 40: 198-203. PMID 22743146 DOI: 10.2967/Jnmt.112.105130  0.32
2012 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1609-17. PMID 22569194 DOI: 10.1038/Jcbfm.2012.60  0.32
2012 Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Annals of Neurology. 71: 560-8. PMID 22522445 DOI: 10.1002/Ana.22691  0.32
2012 Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg D, Cai XW, Ramnath N, Hassan K, Moran J, Eisbruch A, Ten Haken RK, Kong FM. Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 82: e631-8. PMID 22197235 DOI: 10.1016/J.Ijrobp.2011.07.044  0.32
2012 Shafir T, Love T, Berent-Spillson A, Persad CC, Wang H, Reame NK, Frey KA, Zubieta JK, Smith YR. Postmenopausal hormone use impact on emotion processing circuitry. Behavioural Brain Research. 226: 147-53. PMID 21930160 DOI: 10.1016/J.Bbr.2011.09.012  0.32
2011 Smith YR, Bowen L, Love TM, Berent-Spillson A, Frey KA, Persad CC, Reame NK, Koeppe RA, Zubieta JK. Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity. The Journal of Clinical Endocrinology and Metabolism. 96: E1761-70. PMID 21865354 DOI: 10.1210/Jc.2011-0351  0.32
2011 Bohnen NI, Müller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain : a Journal of Neurology. 134: 2358-65. PMID 21653540 DOI: 10.1093/Brain/Awr139  0.32
2011 Hammers D, Spurgeon E, Ryan K, Persad C, Heidebrink J, Barbas N, Albin R, Frey K, Darby D, Giordani B. Reliability of repeated cognitive assessment of dementia using a brief computerized battery American Journal of Alzheimer's Disease and Other Dementias. 26: 326-333. PMID 21636581 DOI: 10.1177/1533317511411907  0.32
2011 Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 848-55. PMID 21571793 DOI: 10.2967/Jnumed.111.089946  0.32
2011 Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain : a Journal of Neurology. 134: 1647-57. PMID 21555336 DOI: 10.1093/Brain/Awr089  0.32
2011 Wong KK, Wynn EA, Myles J, Ackermann RJ, Frey KA, Avram AM. Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumors Clinical Nuclear Medicine. 36: 25-31. PMID 21157203 DOI: 10.1097/Rlu.0B013E3181Feedc0  0.32
2011 Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg D, Curtis JL, Cai XW, Ramnath N, Kalemkerian GP, Ten Haken RK, Eisbruch A, Kong FM. Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 71-8. PMID 21119546 DOI: 10.1097/Jto.0B013E3181F77B40  0.32
2010 Wong KK, Sisson JC, Koral KF, Frey KA, Avram AM. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT. Ajr. American Journal of Roentgenology. 195: 730-6. PMID 20729453 DOI: 10.2214/Ajr.09.3458  0.32
2010 Kochhar R, Brown RK, Wong CO, Dunnick NR, Frey KA, Manoharan P. Role of FDG PET/CT in imaging of renal lesions. Journal of Medical Imaging and Radiation Oncology. 54: 347-57. PMID 20718915 DOI: 10.1111/J.1754-9485.2010.02181.X  0.32
2010 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain : a Journal of Neurology. 133: 1747-54. PMID 20413575 DOI: 10.1093/Brain/Awq079  0.32
2010 Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of Neurology. 67: 440-6. PMID 20385910 DOI: 10.1001/Archneurol.2010.34  0.32
2010 Berent-Spillson A, Persad CC, Love T, Tkaczyk A, Wang H, Reame NK, Frey KA, Zubieta JK, Smith YR. Early menopausal hormone use influences brain regions used for visual working memory. Menopause (New York, N.Y.). 17: 692-9. PMID 20300040 DOI: 10.1097/Gme.0B013E3181Cc49E9  0.32
2010 Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA. In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations Nuclear Medicine and Biology. 37: 3-8. PMID 20122661 DOI: 10.1016/J.Nucmedbio.2009.08.013  0.32
2010 Mody RJ, Bui C, Hutchinson RJ, Yanik GA, Castle VP, Frey KA, Shulkin BL. FDG PET imaging of childhood sarcomas. Pediatric Blood & Cancer. 54: 222-7. PMID 19890901 DOI: 10.1002/Pbc.22307  0.32
2010 Bohnen NI, Müller MLTM, Kotagal V, Koeppe RA, Kilbourn MR, Albin RL, Frey KA. Reply: Cognition and olfaction in Parkinson's disease Brain. 133: e161. DOI: 10.1093/Brain/Awq228  0.32
2009 Bohnen NI, Müller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 73: 1670-6. PMID 19917989 DOI: 10.1212/Wnl.0B013E3181C1Ded6  0.32
2009 Kilbourn MR, Hockley B, Lee L, Sherman P, Quesada C, Frey KA, Koeppe RA. Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter Nuclear Medicine and Biology. 36: 489-493. PMID 19520289 DOI: 10.1016/J.Nucmedbio.2009.02.007  0.32
2009 Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 72: 1390-6. PMID 19380698 DOI: 10.1212/Wnl.0B013E3181A187Dd  0.32
2009 Chepeha DB, Sacco AG, Oxford LE, Karamchandani R, Miller TH, Teknos TN, Bradford CR, Eisbruch A, Worden FM, Urba SG, Mukherji SK, Bui C, Frey KA, Wolf GT, Lee JS. Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy. Head & Neck. 31: 452-60. PMID 19189338 DOI: 10.1002/Hed.21006  0.32
2008 Dillman JR, Brown RK, Frey KA, Quint DJ. Vertebral body hemangioma visualized on Tc-99m HMPAO-labeled leukocyte SPECT/CT. Clinical Nuclear Medicine. 33: 587-90. PMID 18645389 DOI: 10.1097/Rlu.0B013E31817Debbe  0.32
2008 Li X, Jung YW, Snyder SE, Blair J, Sherman PS, Desmond T, Frey KA, Kilbourn MR. 5-tert-Butyl-2-(4′-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAA receptor radioligands Nuclear Medicine and Biology. 35: 549-559. PMID 18589299 DOI: 10.1016/J.Nucmedbio.2007.08.003  0.32
2008 Albin RL, Koeppe RA, Bohnen NI, Wernette K, Kilbourn MA, Frey KA. Spared caudal brainstem SERT binding in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 441-4. PMID 18073772 DOI: 10.1038/Sj.Jcbfm.9600599  0.32
2008 Kilbourn MR, Butch E, Desmond T, Sherman P, Frey K. Dopamine depletion increases in vivo [11C]DTBZ binding in awake rat brain Neuroimage. 41: T54. DOI: 10.1016/J.Neuroimage.2008.04.228  0.32
2007 Kong FM, Frey KA, Quint LE, Ten Haken RK, Hayman JA, Kessler M, Chetty IJ, Normolle D, Eisbruch A, Lawrence TS. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3116-23. PMID 17634490 DOI: 10.1200/Jco.2006.10.3747  0.32
2007 Cameron OG, Huang GC, Nichols T, Koeppe RA, Minoshima S, Rose D, Frey KA. Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Archives of General Psychiatry. 64: 793-800. PMID 17606813 DOI: 10.1001/Archpsyc.64.7.793  0.32
2006 Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. Imaging butyrylcholinesterase activity in Alzheimer's disease. Annals of Neurology. 60: 746. PMID 17192935 DOI: 10.1002/Ana.21023  0.32
2006 Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1831-8. PMID 16991144 DOI: 10.1002/Mds.21039  0.32
2006 Frey KA, Albin RL. Neuroimaging of Tourette syndrome. Journal of Child Neurology. 21: 672-7. PMID 16970868 DOI: 10.1177/08830738060210080501  0.32
2006 Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology. 185: 327-38. PMID 16518646 DOI: 10.1007/S00213-006-0330-6  0.32
2006 Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 1198-212. PMID 16421508 DOI: 10.1038/Sj.Jcbfm.9600276  0.32
2006 Newman EA, Cimmino VM, Sabel MS, Diehl KM, Frey KA, Chang AE, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Annals of Surgical Oncology. 13: 52-7. PMID 16372155 DOI: 10.1245/Aso.2006.12.002  0.32
2006 Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology. 59: 13-20. PMID 16278840 DOI: 10.1002/Ana.20672  0.32
2005 Clinton SM, Ibrahim HM, Frey KA, Davis KL, Haroutunian V, Meador-Woodruff JH. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. The American Journal of Psychiatry. 162: 1859-71. PMID 16199832 DOI: 10.1176/Appi.Ajp.162.10.1859  0.32
2005 Corcoran KA, Desmond TJ, Frey KA, Maren S. Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8978-87. PMID 16192388 DOI: 10.1523/Jneurosci.2246-05.2005  0.32
2005 Hamstra DA, Moffat BA, Hall DE, Young JM, Desmond TJ, Carter J, Pietronigro D, Frey KA, Rehemtulla A, Ross BD. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study. Journal of Neuro-Oncology. 73: 225-38. PMID 15980973 DOI: 10.1007/S11060-004-5675-2  0.32
2005 Koeppe RA, Gilman S, Joshi A, Liu S, Little R, Junck L, Heumann M, Frey KA, Albin RL. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 936-44. PMID 15937303  0.32
2004 Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain Experimental Neurology. 188: 387-390. PMID 15246838 DOI: 10.1016/J.Expneurol.2004.05.001  0.32
2004 Minoshima S, Frey KA, Cross DJ, Kuhl DE. Neurochemical imaging of dementias. Seminars in Nuclear Medicine. 34: 70-82. PMID 14735460 DOI: 10.1053/J.Semnuclmed.2003.09.008  0.32
2004 Montgomery EB, Pan T, Le W, Jankovic J, Ahlskog JE, Wooten GF, Albin RL, Frey KA. Slowing Parkinson's disease progression: Recent dopamine agonist trials [3] (multiple letters) Neurology. 62: 343-345. DOI: 10.1212/Wnl.62.2.343  0.32
2003 Maren S, Ferrario CR, Corcoran KA, Desmond TJ, Frey KA. Protein synthesis in the amygdala, but not the auditory thalamus, is required for consolidation of Pavlovian fear conditioning in rats. The European Journal of Neuroscience. 18: 3080-8. PMID 14656303 DOI: 10.1111/J.1460-9568.2003.03063.X  0.32
2003 Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice R, Shults CW, Stoessl AJ. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease Experimental Neurology. 184. PMID 14597329 DOI: 10.1016/J.Expneurol.2003.08.008  0.32
2003 Kemmerer ES, Desmond TJ, Albin RL, Kilbourn MR, Frey KA. Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Experimental Neurology. 183: 81-6. PMID 12957491 DOI: 10.1016/S0014-4886(03)00096-7  0.32
2003 Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 61: 310-5. PMID 12913189 DOI: 10.1212/01.Wnl.0000076181.39162.Fc  0.32
2003 Albin RL, Cross D, Cornblath WT, Wald JA, Wernette K, Frey KA, Minoshima S. Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Annals of Neurology. 53: 528-32. PMID 12666122 DOI: 10.1002/Ana.10527  0.32
2003 Albin RL, Frey KA. Initial agonist treatment of Parkinson disease: a critique. Neurology. 60: 390-4. PMID 12580185 DOI: 10.1212/01.Wnl.0000052681.28286.52  0.32
2002 Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. Journal of Geriatric Psychiatry and Neurology. 15: 200-9. PMID 12489916 DOI: 10.1177/089198870201500405  0.32
2002 Albin RL, Nichols TE, Frey KA. Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. Jama. 288: 311-2; author reply . PMID 12117386  0.32
2002 Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Annals of Neurology. 51: 767-71. PMID 12112084 DOI: 10.1002/Ana.10186  0.32
2002 Suzuki M, Desmond TJ, Albin RL, Frey KA. Cholinergic vesicular transporters in progressive supranuclear palsy. Neurology. 58: 1013-8. PMID 11940684 DOI: 10.1212/Wnl.58.7.1013  0.32
2002 Gau JT, Steinhilb ML, Kao TC, D'Amato CJ, Gaut JR, Frey KA, Turner RS. Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice. The American Journal of Pathology. 160: 731-8. PMID 11839594 DOI: 10.1016/S0002-9440(10)64893-6  0.32
2001 Frey KA, Albin RL. Receptor binding techniques. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit1.4. PMID 18428450 DOI: 10.1002/0471142301.Ns0104S00  0.32
2001 Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology. 50: 358-65. PMID 11558792 DOI: 10.1002/Ana.1133  0.32
2001 Suzuki M, Desmond TJ, Albin RL, Frey KA. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse (New York, N.Y.). 41: 329-36. PMID 11494403 DOI: 10.1002/Syn.1089  0.32
2001 Zubieta JK, Koeppe RA, Frey KA, Kilbourn MR, Mangner TJ, Foster NL, Kuhl DE. Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse (New York, N.Y.). 39: 275-87. PMID 11169777 DOI: 10.1002/1098-2396(20010315)39:4<275::Aid-Syn1010>3.0.Co;2-3  0.32
2001 Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry. 49: 110-6. PMID 11164757 DOI: 10.1016/S0006-3223(00)00981-1  0.32
2000 Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, Frey KA, Aldrich MS. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 55: 1410-2. PMID 11087796 DOI: 10.1212/Wnl.55.9.1410  0.32
2000 Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS, Desmond TJ, Frey KA. Synthesis, 18F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors Journal of Medicinal Chemistry. 43: 4552-4562. PMID 11087580 DOI: 10.1021/Jm000305O  0.32
2000 Taylor SF, Koeppe RA, Tandon R, Zubieta JK, Frey KA. In vivo measurement of the vesicular monoamine transporter in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 667-75. PMID 11063922 DOI: 10.1016/S0893-133X(00)00165-2  0.32
2000 Zubieta JK, Huguelet P, Ohl LE, Koeppe RA, Kilbourn MR, Carr JM, Giordani BJ, Frey KA. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. The American Journal of Psychiatry. 157: 1619-28. PMID 11007716 DOI: 10.1176/Appi.Ajp.157.10.1619  0.32
2000 Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA. Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Annals of Neurology. 48: 391-5. PMID 10976649 DOI: 10.1002/1531-8249(200009)48:3<391::Aid-Ana17>3.0.Co;2-H  0.32
2000 Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 54: 1753-9. PMID 10802780 DOI: 10.1212/Wnl.54.9.1753  0.32
2000 Cowell RM, Kantor L, Hewlett GH, Frey KA, Gnegy ME. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. European Journal of Pharmacology. 389: 59-65. PMID 10686296 DOI: 10.1016/S0014-2999(99)00828-6  0.32
1999 Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1376-84. PMID 10598942 DOI: 10.1097/00004647-199912000-00011  0.32
1999 Koeppe RA, Frey KA, Snyder SE, Meyer P, Kilbourn MR, Kuhl DE. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1150-63. PMID 10532640 DOI: 10.1097/00004647-199910000-00012  0.32
1999 Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53: 371-4. PMID 10430428 DOI: 10.1212/Wnl.53.2.371  0.32
1999 Bohnen NI, Albin RL, Frey KA, Fink JK. (+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis. Neurology. 52: 1067-9. PMID 10102431 DOI: 10.1212/Wnl.52.5.1067  0.32
1999 Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 52: 691-9. PMID 10078712 DOI: 10.1212/Wnl.52.4.691  0.32
1999 Little KY, Zhang L, Desmond T, Frey KA, Dalack GW, Cassin BJ. Striatal dopaminergic abnormalities in human cocaine users American Journal of Psychiatry. 156: 238-245. PMID 9989560 DOI: 10.1176/Ajp.156.2.238  0.32
1999 Pennell PB, Burdette DE, Ross DA, Henry TR, Albin RL, Sackellares JC, Frey KA. Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia. 40: 38-46. PMID 9924900 DOI: 10.1111/J.1528-1157.1999.Tb01986.X  0.32
1999 Snyder SE, Sherman PS, Desmond TJ, Frey KA, Kilbourn MR. (-)-6',7'-[11C]dihydroroten-12α-ol ((-)-[11C]DHROL) for in vivo measurement of mitochondrial complex I Journal of Labelled Compounds and Radiopharmaceuticals. 42: 641-652. DOI: 10.1002/(Sici)1099-1344(199907)42:7<641::Aid-Jlcr226>3.0.Co;2-Y  0.32
1998 Mulholland GK, Wieland DM, Kilbourn MR, Frey KA, Sherman PS, Carey JE, Kuhl DE. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse (New York, N.Y.). 30: 263-74. PMID 9776130 DOI: 10.1002/(Sici)1098-2396(199811)30:3<263::Aid-Syn4>3.0.Co;2-9  0.32
1998 Kearney JA, Becker JB, Frey KA, Albin RL. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation. Neuroscience. 87: 881-91. PMID 9759976 DOI: 10.1016/S0306-4522(98)00193-6  0.32
1998 Zubieta JK, Koeppe RA, Mulholland GK, Kuhl DE, Frey KA. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 619-31. PMID 9626186 DOI: 10.1097/00004647-199806000-00004  0.32
1998 Frey KA, Wieland DM, Kilbourn MR. Imaging of monoaminergic and cholinergic vesicular transporters in the brain Advances in Pharmacology (San Diego, Calif.). 42: 269-272. PMID 9327896 DOI: 10.1016/S1054-3589(08)60745-0  0.32
1997 Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 919-31. PMID 9307605 DOI: 10.1097/00004647-199709000-00001  0.32
1997 Turner RS, Chervin RD, Frey KA, Minoshima S, Kuhl DE. Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Neurology. 49: 523-7. PMID 9270589 DOI: 10.1212/Wnl.49.2.523  0.32
1997 Dwamena BA, Belcher KK, Dasika N, Frey KA. Focal hyperemia on RBC blood-flow imaging. A scintigraphic marker of arterioportal venous shunting in hepatic cavernous hemangiomas? Clinical Nuclear Medicine. 22: 542-5. PMID 9262900 DOI: 10.1097/00003072-199708000-00006  0.32
1997 Macdonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology (Baltimore, Md.). 26: 277-82. PMID 9252134 DOI: 10.1002/Hep.510260204  0.32
1997 Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Annals of Neurology. 42: 85-94. PMID 9225689 DOI: 10.1002/Ana.410420114  0.32
1997 Kilbourn MR, Charalambous A, Frey KA, Sherman P, Higgins DS, Greenamyre JT. Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 265-72. PMID 9119899 DOI: 10.1097/00004647-199703000-00003  0.32
1997 Kearney JAF, Frey KA, Albin RL. Metabotropic Glutamate Agonist-Induced Rotation: A Pharmacological, FOS Immunohistochemical, and [14C]-2-Deoxyglucose Autoradiographic Study The Journal of Neuroscience. 17: 4415-4425. DOI: 10.1523/Jneurosci.17-11-04415.1997  0.32
1996 Gilman S, Frey KA, Koeppe RA, Junck L, Little R, Vander Borght TM, Lohman M, Martorello S, Lee LC, Jewett DM, Kilbourn MR. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Annals of Neurology. 40: 885-92. PMID 9007093 DOI: 10.1002/Ana.410400610  0.32
1996 Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of Neurology. 40: 873-84. PMID 9007092 DOI: 10.1002/Ana.410400609  0.32
1996 Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC, Kilbourn MR, Kuhl DE. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 1288-99. PMID 8898703 DOI: 10.1097/00004647-199611000-00025  0.32
1996 Buck A, Mulholland GK, Papadopoulos SM, Koeppe RA, Frey KA. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection Journal of Cerebral Blood Flow and Metabolism. 16: 1280-1287. PMID 8898702 DOI: 10.1097/00004647-199611000-00024  0.32
1996 Kilbourn MR, Frey KA, Vander Borght T, Sherman PS. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters Nuclear Medicine and Biology. 23: 467-471. PMID 8832701 DOI: 10.1016/0969-8051(96)00023-6  0.32
1996 Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Wieland DM, Koeppe RA. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Annals of Neurology. 40: 399-410. PMID 8797529 DOI: 10.1002/Ana.410400309  0.32
1996 Jung YW, Frey KA, Mulholland GK, del Rosario R, Sherman PS, Raffel DM, Van Dort ME, Kuhl DE, Gildersleeve DL, Wieland DM. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. Journal of Medicinal Chemistry. 39: 3331-42. PMID 8765517 DOI: 10.1021/Jm9507486  0.32
1996 Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AA. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 47: 462-6. PMID 8757021 DOI: 10.1212/Wnl.47.2.462  0.32
1996 Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 409-17. PMID 8621745 DOI: 10.1097/00004647-199605000-00007  0.32
1996 Lee KS, Frey KA, Koeppe RA, Buck A, Mulholland GK, Kuhl DE. In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 303-10. PMID 8594063 DOI: 10.1097/00004647-199603000-00016  0.32
1996 Lee LC, Borght TV, Sherman PS, Frey KA, Kilbourn MR. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter Journal of Medicinal Chemistry. 39: 191-196. PMID 8568807 DOI: 10.1021/Jm950117B  0.32
1995 Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. European Journal of Pharmacology. 294: 577-83. PMID 8750721 DOI: 10.1016/0014-2999(95)00594-3  0.32
1995 Vander Borght TM, Sima AA, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA. [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience. 68: 955-62. PMID 8577387 DOI: 10.1016/0306-4522(95)00167-H  0.32
1995 Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Archives of Neurology. 52: 314-7. PMID 7872887 DOI: 10.1001/Archneur.1995.00540270110027  0.32
1995 Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, Sackellares JC, Albin RL. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 45: 934-41. PMID 7746410 DOI: 10.1212/Wnl.45.5.934  0.32
1995 Mulholland GK, Kilbourn MR, Sherman P, Carey JE, Frey KA, Koeppe RA, Kuhl DE. Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nuclear Medicine and Biology. 22: 13-7. PMID 7735163 DOI: 10.1016/0969-8051(94)00082-U  0.32
1995 Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. Journal of Computer Assisted Tomography. 19: 541-7. PMID 7622680 DOI: 10.1097/00004728-199507000-00006  0.32
1995 Charalambous A, Tluczek L, Frey KA, Higgins DS, Greenamyre TJ, Kilbourn MR. Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. Nuclear Medicine and Biology. 22: 491-6. PMID 7550026 DOI: 10.1016/0969-8051(94)00129-8  0.32
1994 Koeppe RA, Frey KA, Mulholland GK, Kilbourn MR, Buck A, Lee KS, Kuhl DE. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 85-99. PMID 8263062 DOI: 10.1038/Jcbfm.1994.13  0.32
1994 Casey KL, Minoshima S, Berger KL, Koeppe RA, Morrow TJ, Frey KA. Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. Journal of Neurophysiology. 71: 802-7. PMID 8176441 DOI: 10.1152/Jn.1994.71.2.802  0.32
1994 Albin RL, Howland MM, Higgins DS, Frey KA. Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain. Neurochemical Research. 19: 581-9. PMID 8065514 DOI: 10.1007/Bf00971334  0.32
1994 Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA. Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience. 63: 207-21. PMID 7898649 DOI: 10.1016/0306-4522(94)90017-5  0.32
1993 Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography. Journal of Neurochemistry. 60: 2315-8. PMID 8492135 DOI: 10.1111/J.1471-4159.1993.Tb03521.X  0.32
1993 Henry TR, Frey KA, Sackellares JC, Gilman S, Koeppe RA, Brunberg JA, Ross DA, Berent S, Young AB, Kuhl DE. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. 43: 1998-2006. PMID 8413957 DOI: 10.1212/Wnl.43.10.1998  0.32
1993 Meyer MA, Frey KA, Schwaiger M. Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess. Clinical Nuclear Medicine. 18: 682-4. PMID 8403702 DOI: 10.1097/00003072-199308000-00013  0.32
1993 Holthoff VA, Koeppe RA, Frey KA, Penney JB, Markel DS, Kuhl DE, Young AB. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Annals of Neurology. 34: 76-81. PMID 8390806 DOI: 10.1002/Ana.410340114  0.32
1993 Schwartz DR, Schacht J, Miller JM, Frey K, Altschuler RA. Chronic electrical stimulation reverses deafness-related depression of electrically evoked 2-deoxyglucose activity in the guinea pig inferior colliculus. Hearing Research. 70: 243-9. PMID 8294268 DOI: 10.1016/0378-5955(93)90162-T  0.32
1992 Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RL, Carey JE, Wieland DM, Kuhl DE, Agranoff BW. In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 12: 147-54. PMID 1727135 DOI: 10.1038/Jcbfm.1992.18  0.32
1991 Frey KA, Ciliax B, Agranoff BW. Quantitative in vivo receptor binding. IV: Detection of muscarinic receptor down-regulation by equilibrium and by tracer kinetic methods. Neurochemical Research. 16: 1017-23. PMID 1784328 DOI: 10.1007/Bf00965845  0.32
1991 Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Annals of Neurology. 30: 663-72. PMID 1662476 DOI: 10.1002/Ana.410300506  0.32
1991 Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 735-44. PMID 1651944 DOI: 10.1038/Jcbfm.1991.130  0.32
1988 Shimoyama I, Dauth GW, Gilman S, Frey KA, Penney JB. Thalamic, brainstem, and cerebellar glucose metabolism in the hemiplegic monkey. Annals of Neurology. 24: 718-26. PMID 3207355 DOI: 10.1002/Ana.410240605  0.32
1988 Agranoff BW, Fisher SK, Heacock AM, Frey KA. The phosphoinositide-linked CNS muscarinic receptor. Advances in Experimental Medicine and Biology. 236: 195-215. PMID 2853563 DOI: 10.1007/978-1-4757-5971-6_16  0.32
1987 Gilman S, Dauth GW, Frey KA, Penney JB. Experimental hemiplegia in the monkey: basal ganglia glucose activity during recovery. Annals of Neurology. 22: 370-6. PMID 3674802 DOI: 10.1002/Ana.410220314  0.32
1985 Olds JL, Frey KA, Ehrenkaufer RL, Agranoff BW. A sequential double-label autoradiographic method that quantifies altered rates of regional glucose metabolism. Brain Research. 361: 217-24. PMID 4084794 DOI: 10.1016/0006-8993(85)91292-2  0.32
1985 Dauth GW, Gilman S, Frey KA, Penney JB. Basal ganglia glucose utilization after recent precentral ablation in the monkey. Annals of Neurology. 17: 431-8. PMID 4004167 DOI: 10.1002/Ana.410170503  0.32
1985 Frey KA, Hichwa RD, Ehrenkaufer RL, Agranoff BW. Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding. Proceedings of the National Academy of Sciences of the United States of America. 82: 6711-5. PMID 3876561 DOI: 10.1073/Pnas.82.19.6711  0.32
1984 Agranoff BW, Frey KA. A regional metabolic contrast method for the study of brain pathology. Annals of Neurology. 15: S93-7. PMID 6331284 DOI: 10.1002/Ana.410150717  0.32
1983 Frey KA, Agranoff BW. Barbiturate-enhanced detection of brain lesions by carbon-14-labeled 2-deoxyglucose autoradiography. Science (New York, N.Y.). 219: 879-81. PMID 6823556 DOI: 10.1126/Science.6823556  0.32
1983 Pan HS, Frey KA, Young AB, Penney JB. Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 3: 1189-98. PMID 6304260 DOI: 10.1523/Jneurosci.03-06-01189.1983  0.32
1981 Fisher SK, Frey KA, Agranoff BW. Loss of muscarinic receptors and of stimulated phospholipid labeling in ibotenate-treated hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 1: 1407-13. PMID 7320753 DOI: 10.1523/Jneurosci.01-12-01407.1981  0.32
1981 Frey KA, Wieland DM, Brown LE, Rogers WL, Agranoff BW. Development of a tomographic myelin scan. Annals of Neurology. 10: 214-21. PMID 6975058 DOI: 10.1002/Ana.410100303  0.32
1981 Penney JB, Frey K, Young AB. Quantitative autoradiography of neurotransmitter receptors using tritium-sensitive film. European Journal of Pharmacology. 72: 421-2. PMID 6268430 DOI: 10.1016/0014-2999(81)90591-4  0.32
Show low-probability matches.